These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 24618222)

  • 21. Validation of potential classification criteria for systemic sclerosis.
    Johnson SR; Fransen J; Khanna D; Baron M; van den Hoogen F; Medsger TA; Peschken CA; Carreira PE; Riemekasten G; Tyndall A; Matucci-Cerinic M; Pope JE
    Arthritis Care Res (Hoboken); 2012 Mar; 64(3):358-67. PubMed ID: 22052658
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autoantibody profile and clinical correlation in a group of patients with systemic sclerosis in southern Brazil.
    Müller Cde S; Paiva Edos S; Azevedo VF; Radominski SC; Lima Filho JH
    Rev Bras Reumatol; 2011; 51(4):314-8, 323-4. PubMed ID: 21779708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A subset of systemic sclerosis but not of systemic lupus erythematosus is defined by isolated anti-Ku autoantibodies.
    Cavazzana I; Fredi M; Taraborelli M; Quinzanini M; Tincani A; Franceschini F
    Clin Exp Rheumatol; 2013; 31(2 Suppl 76):118-21. PubMed ID: 23910615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Joint contractures responsive to immunosuppressive therapy in a girl with childhood-onset systemic sclerosis double-seropositive for rare anti-nucleolar autoantibodies: a case report.
    Tanaka R; Tani Y; Kaburaki Y; Kinoshita M; Kawaguchi Y; Okazaki Y; Kuwana M; Harigai M; Nagata S; Miyamae T
    Pediatr Rheumatol Online J; 2021 Mar; 19(1):37. PubMed ID: 33743728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic accuracy and predictive value of autoantibody profiles in patients with systemic sclerosis: a single-center study.
    Zhang X; Zhang H; Zhao J; Li Y; Wang H; Li C
    Clin Rheumatol; 2023 May; 42(5):1297-1306. PubMed ID: 36604358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis.
    Hamaguchi Y
    J Dermatol; 2010 Jan; 37(1):42-53. PubMed ID: 20175839
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Belgian Systemic Sclerosis Cohort: correlations between disease severity scores, cutaneous subsets, and autoantibody profile.
    Vanthuyne M; Smith V; De Langhe E; Van Praet J; Arat S; Depresseux G; Westhovens R; Blockmans D; Badot V; Cogan E; De Keyser F; Houssiau FA
    J Rheumatol; 2012 Nov; 39(11):2127-33. PubMed ID: 22984273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical features of patients with systemic sclerosis positive for anti-SS-A antibody: a cohort study of 156 patients.
    Watanabe T; Ototake Y; Akita A; Suzuki M; Kanaoka M; Tamura J; Saigusa Y; Yamaguchi Y
    Arthritis Res Ther; 2024 May; 26(1):93. PubMed ID: 38702799
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distinctive autoantibody profile in Mexican Mestizo systemic sclerosis patients.
    Rodriguez-Reyna TS; Hinojosa-Azaola A; Martinez-Reyes C; Nuñez-Alvarez CA; Torrico-Lavayen R; García-Hernández JL; Cabiedes-Contreras J
    Autoimmunity; 2011 Nov; 44(7):576-84. PubMed ID: 21875377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The clinical phenotype of systemic sclerosis patients with anti-PM/Scl antibodies: results from the EUSTAR cohort.
    Lazzaroni MG; Marasco E; Campochiaro C; DeVries-Bouwstra J; Gonzalez-Perez MI; Rojas-Serrano J; Hachulla E; Zanatta E; Barsotti S; Furini F; Triantafyllias K; Abignano G; Truchetet ME; De Luca G; De Langhe E; Hesselstrand R; Ingegnoli F; Bertoldo E; Smith V; Bellando-Randone S; Poormoghim H; Colombo E; Ceribelli A; Furloni A; Zingarelli S; Cavazzana I; Franceschini F; Del Galdo F; Denton CP; Cavagna L; Distler O; Allanore Y; Airò P;
    Rheumatology (Oxford); 2021 Nov; 60(11):5028-5041. PubMed ID: 33580257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autoantibodies in scleroderma and their association with the clinical profile of the disease. A study of 66 patients from southern Brazil.
    Skare TL; Fonseca AE; Luciano AC; Azevedo PM
    An Bras Dermatol; 2011; 86(6):1075-81. PubMed ID: 22281893
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival in systemic sclerosis-pulmonary arterial hypertension by serum autoantibody status in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) Registry.
    Hinchcliff M; Khanna S; Hsu VM; Lee J; Almagor O; Chang RW; Steen V; Chung L;
    Semin Arthritis Rheum; 2015 Dec; 45(3):309-14. PubMed ID: 26210782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autoantibodies in scleroderma.
    Pollard KM; Reimer G; Tan EM
    Clin Exp Rheumatol; 1989; 7 Suppl 3():S57-62. PubMed ID: 2691161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Using Autoantibodies and Cutaneous Subset to Develop Outcome-Based Disease Classification in Systemic Sclerosis.
    Nihtyanova SI; Sari A; Harvey JC; Leslie A; Derrett-Smith EC; Fonseca C; Ong VH; Denton CP
    Arthritis Rheumatol; 2020 Mar; 72(3):465-476. PubMed ID: 31682743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The diagnostic and prognostic value of a line immunoblot assay in Taiwanese patients with systemic sclerosis.
    Yen TH; Chen JP; Hsieh TY; Hung WT; Lai KL; Hsieh CW; Chen HH; Huang WN; Chen YH; Chen YM
    Clin Chim Acta; 2023 Jul; 547():117457. PubMed ID: 37390945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Demographic and clinical features of systemic sclerosis patients with anti-RNA polymerase III antibodies.
    Motegi S; Toki S; Yamada K; Uchiyama A; Ishikawa O
    J Dermatol; 2015 Feb; 42(2):189-92. PubMed ID: 25483258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and serologic correlates of anti-PM/Scl antibodies in systemic sclerosis: a multicenter study of 763 patients.
    D'Aoust J; Hudson M; Tatibouet S; Wick J; ; Mahler M; Baron M; Fritzler MJ
    Arthritis Rheumatol; 2014 Jun; 66(6):1608-15. PubMed ID: 24577935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of anti-RNA polymerase III autoantibodies and cancer in scleroderma.
    Moinzadeh P; Fonseca C; Hellmich M; Shah AA; Chighizola C; Denton CP; Ong VH
    Arthritis Res Ther; 2014 Feb; 16(1):R53. PubMed ID: 24524733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autoantibody to Th ribonucleoprotein (nucleolar 7-2 RNA protein particle) in patients with systemic sclerosis.
    Okano Y; Medsger TA
    Arthritis Rheum; 1990 Dec; 33(12):1822-8. PubMed ID: 1701994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serological profile of patients with systemic sclerosis.
    Wielosz E; Dryglewska M; Majdan M
    Postepy Hig Med Dosw (Online); 2014 Aug; 68():987-91. PubMed ID: 25228505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.